# US Hemorrhoids Treatment Market

> US Hemorrhoids Treatment Market Research Report Information by Type (External Hemorrhoids, Internal Hemorrhoids, Prolapsed Hemorrhoids), By Treatment Type (Surgical, Nonsurgical), By Specialist (Proctologist, General Physician, Gastroenterologist, Others) By End-User (Hospitals and Clinics, Ambulatory surgical centers, Others) - Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.87%
- **2024:** $ 302.73 Million
- **2025:** $ 323.53 Million
- **2035:** $ 628.87 Million
- **Key Players:** Johnson & Johnson (US), Bayer AG (DE), Procter & Gamble Co (US), Medtronic plc (IE), Hollister Incorporated (US), SurgiCare (US), B. Braun Melsungen AG (DE), Smith & Nephew plc (GB), Coloplast A/S (DK)

**Report ID:** MRFR/HC/14733-CR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** July 28, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-hemorrhoids-treatment-market-16261

---

## Market Summary

## **US Hemorrhoids Treatment Market Overview**

As per MRFR analysis, the US Hemorrhoids Treatment Market Size was estimated at 1.67 (USD Billion) in 2024. The US Hemorrhoids Treatment Market Industry is expected to grow from 1.75 (USD Billion) in 2025 to 2.62 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.58% during the forecast period (2025 - 2034). Increasing prevalence of hemorrhoids and new approaches to treat hemorrhoids are driving the market growth.

Source: Secondary Research, Primary Research, _Market Research Future_ Database, and Analyst Review

## **US Hemorrhoids Treatment Market Trends**

### **Increasing prevalence of hemorrhoids is expected to boost the market growth**

The U.S. hemorrhoid treatment market is currently undergoing a significant expansion, primarily fueled by the rising prevalence of hemorrhoids and a multitude of contributing factors. According to the US Department of Health and Human Services, the total number of people suffering from hemorrhoids in the United States is estimated to be around 10.4 million, with 1 million new cases diagnosed each year. Hemorrhoids, characterized by the swelling of veins in the rectum and anus, have become a pervasive health concern in the United States.

This increase in prevalence can be attributed to several key factors, including contemporary lifestyle choices and dietary habits. The modern sedentary way of life, often characterized by prolonged periods of sitting, coupled with diets lacking in essential dietary fiber, has made hemorrhoids a more common affliction.

In addition to awareness, ongoing research and development efforts have led to remarkable advancements in the field of hemorrhoid treatment. [Minimally invasive](../../../reports/minimally-invasive-cosmetic-procedures-market-5923) procedures, innovative medications, and cutting-edge technologies have emerged as novel approaches to managing this condition. These advancements not only improve treatment outcomes but also contribute to the overall expansion of the market as patients and healthcare providers seek more effective and patient-friendly options. The availability of healthcare infrastructure and specialized medical professionals further catalyzes the market's growth. Access to healthcare facilities and clinics that offer hemorrhoid treatment options is essential for patients seeking relief from this condition.

Moreover, Patients grappling with hemorrhoids prioritize treatments that offer relief from the pain and discomfort associated with the condition, ultimately enhancing their quality of life. The market is further bolstered by the presence of Over the Counter (OTC) products, such as creams, ointments, and suppositories, which provide convenient and accessible solutions for individuals looking to manage mild hemorrhoid symptoms independently.

## **US Hemorrhoids Treatment Market Segment Insights**

### **US Hemorrhoids Treatment Market Insights**

The US Hemorrhoids Treatment market segmentation, based on Type, includes External Hemorrhoids, Internal Hemorrhoids, and Prolapsed Hemorrhoids. The Internal Hemorrhoids segment is to hold the majority share in 2022 in the US Hemorrhoids Treatment market revenue. This is because of the aging population, there is an increasing prevalence of internal hemorrhoids, spurring demand for effective remedies. Heightened awareness and education contribute to a proactive approach among individuals seeking treatment. Advances in medical technologies and a trend favoring minimally invasive procedures, such as rubber band ligation and infrared coagulation, are shaping the landscape.

Additionally, the availability of over-the-counter products underscores a broader market for self-management. Monitoring these trends will provide a comprehensive understanding of the evolving landscape of internal hemorrhoid treatments and their continued growth in the US.

### **US Hemorrhoids Treatment Type Insights**

The US Hemorrhoids Treatment market segmentation is based on a Treatment Type, that includes Surgical, and nonsurgical. The non-surgical segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the rise of effective and convenient treatments, and the market's expansion is further supported by increased awareness, education, and the availability of over-the-counter products, creating a comprehensive landscape for managing hemorrhoids in the US.

### **US Hemorrhoids Treatment Indication Insights**

The US Hemorrhoids Treatment market segmentation is based on a Specialist, that includes Proctologist, General Physician, Gastroenterologist, and Others. The Proctologist specialist segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the prevalence of hemorrhoids rising, especially among an aging population, and the demand for specialized care provided by proctologists is escalating. These specialists contribute significantly to the market's expansion by offering tailored and effective treatments, utilizing their expertise in both surgical and nonsurgical interventions.

The increasing awareness of the importance of seeking specialized medical advice for hemorrhoid management further reinforces the market's growth trajectory in the United States.

**Figure 2: US HEMORRHOIDS TREATMENT MARKET, BY INDICATION, 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database, and Analyst Review

### **US Hemorrhoids Treatment End User Insights**

The US Hemorrhoids Treatment market segmentation is based on end-user that Hospital & clinics, Ambulatory surgical centers, and Others. The hospital & clinics segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2024-2032. This is due to as the prevalence of hemorrhoids increases, these healthcare facilities serve as crucial hubs for diagnosis, treatment, and management. Specialized gastrointestinal units in hospitals and dedicated proctology services in clinics contribute significantly to the market's expansion.

### **US Hemorrhoids Treatment Country Insights**

The US hemorrhoid treatment market is growing due to a rising prevalence of hemorrhoids, particularly among an aging demographic, and the demand for effective treatments is increasing. The market's trajectory is shaped by advancements in medical technologies, a trend towards less invasive procedures, and the expertise of proctologist specialists. Additionally, hospitals and clinics play a crucial role in providing comprehensive care, offering a range of treatment options, and contributing significantly to the market's expansion. Increased awareness, education, and the availability of over-the-counter products further bolster the growth of the hemorrhoids treatment market, creating a dynamic landscape in the United States.

## **US Hemorrhoids Treatment Key Market Players & Competitive Insights**

The US Hemorrhoids Treatment market is characterized by the presence of many players. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the US with diverse Type portfolios. Companies such as Medtronic Plc (Ireland), Cook Medical, Pfizer Inc (US), Boston Scientific Corporation (US) are dominate the US Hemorrhoids Treatment market due to Type differentiation, financial stability, strategic services, and diversified regional presence. The players are focused on investing in extensive research and development as well.

Furthermore, they adopt strategic growth initiatives, such as expansion, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

One of the primary business strategies adopted by manufacturers in the US hemorrhoid treatment industry to benefit clients and expand the healthcare counseling market sector is to manufacture locally to reduce operating costs.

### **Key Companies in the US Hemorrhoids Treatment Market include**

- Medtronic Plc (Ireland)
- CONMED Corporation (US)
- [Cook Medical](https://www.cookmedical.com/products/esc_hmbltri_webds/) (US)
- Pfizer Inc (US)
- Abbott Laboratories (US)
- [Boston Scientific Corporation](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-radiology/peripheral-embolisation-solutions/pelvic-pain/hemorrhoid.html) (US)
- Integra Life Sciences (US)
- Sklar Surgical Instruments (US)
- Privi Medical (US)
- Olympus Corporation (Japan)

## **US Hemorrhoids Treatment Industry Developments**

**In June 2022,** ProNova Partners (US), a mergers and acquisitions firm based in the United States, was permitted to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive device to eliminate hemorrhoids.

**In June 2022,**Medtronic (Ireland) announced the launch of its new hemorrhoid treatment device, the HET Bipolar System, which treats internal hemorrhoids in a gentle, non-surgical manner. The system delivers bipolar energy to the hemorrhoid tissue, which causes coagulation and subsequent necrosis.

## **US Hemorrhoids Treatment Market Segmentation**

### **US Hemorrhoids Treatment Type Outlook**

- External Hemorrhoids
- Internal Hemorrhoids
- Prolapsed Hemorrhoids

### **US Hemorrhoids Treatment Type Outlook**

### **US Hemorrhoids Treatment Specialist Outlook**

- Proctologist
- General Physician
- Gastroenterologist
- Others

### **US Hemorrhoids Treatment End User Outlook**

- Hospital & clinics
- Ambulatory surgical centers
- Others

## Market Drivers

### Rising Healthcare Expenditure

The increasing healthcare expenditure in the US is a significant driver for the [hemorrhoids treatment](https://www.marketresearchfuture.com/reports/hemorrhoids-treatment-market-6999) market. As individuals allocate more resources towards health and wellness, the demand for effective treatment options is likely to rise. In 2025, healthcare spending is projected to reach approximately $4.5 trillion, reflecting a growing commitment to addressing various health issues, including hemorrhoids. This trend may lead to greater investments in research and development, resulting in the introduction of new treatment modalities. Furthermore, as insurance coverage expands, more patients may seek treatment for hemorrhoids, thereby boosting market growth. The correlation between healthcare spending and treatment accessibility is expected to play a pivotal role in shaping the future of the hemorrhoids treatment market.

### Increasing Prevalence of Hemorrhoids

The rising incidence of hemorrhoids in the US population is a crucial driver for the hemorrhoids treatment market. Factors such as sedentary lifestyles, poor dietary habits, and an aging population contribute to this trend. According to recent estimates, approximately 50% of adults will experience hemorrhoids by the age of 50. This growing prevalence necessitates effective treatment options, thereby expanding the market. As more individuals seek relief from symptoms, the demand for various treatment modalities, including over-the-counter medications and surgical interventions, is likely to increase. Consequently, healthcare providers are focusing on developing innovative solutions to address this widespread condition, further propelling the hemorrhoids treatment market forward.

### Advancements in Treatment Technologies

Technological innovations in the field of hemorrhoids treatment are significantly influencing the market landscape. The introduction of minimally invasive procedures, such as rubber band ligation and infrared coagulation, has transformed patient experiences and outcomes. These advancements not only reduce recovery times but also enhance the effectiveness of treatments. The hemorrhoids treatment market is witnessing a shift towards these modern techniques, as they offer patients less discomfort and quicker return to daily activities. Furthermore, the integration of laser technology and radiofrequency ablation is expected to gain traction, potentially increasing the market's value. As healthcare providers adopt these advanced methods, the overall treatment landscape is evolving, catering to the needs of a diverse patient population.

### Increased Focus on Preventive Healthcare

The shift towards preventive healthcare is emerging as a vital driver for the hemorrhoids treatment market. As healthcare systems prioritize prevention over treatment, there is a growing emphasis on educating patients about lifestyle changes that can reduce the risk of developing hemorrhoids. This proactive approach encourages individuals to adopt healthier habits, such as improved diet and regular exercise, which may decrease the incidence of the condition. Consequently, the market is likely to benefit from a dual focus on treatment and prevention, as healthcare providers develop comprehensive strategies to address hemorrhoids. This trend not only enhances patient outcomes but also fosters a more sustainable healthcare model, potentially leading to long-term growth in the hemorrhoids treatment market.

### Growing Awareness and Education Initiatives

Increased awareness regarding hemorrhoids and their treatment options is driving growth in the hemorrhoids treatment market. Educational campaigns by healthcare organizations aim to inform the public about the condition, its causes, and available treatments. This heightened awareness encourages individuals to seek medical advice and explore treatment options sooner. As a result, the market is likely to see a rise in demand for both preventive measures and therapeutic solutions. Additionally, healthcare providers are emphasizing the importance of lifestyle modifications, such as dietary changes and exercise, which can help mitigate symptoms. This focus on education not only empowers patients but also fosters a proactive approach to managing hemorrhoids, thereby enhancing the overall market dynamics.

## Future Outlook

The hemorrhoids treatment market is projected to grow at a 6.87% CAGR from 2025 to 2035, driven by increasing awareness and innovative treatment options.

**New opportunities:**

- Development of telehealth platforms for remote consultations
- Investment in biodegradable and eco-friendly treatment products
- Expansion of over-the-counter product lines in retail pharmacies

By 2035, the market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Treatment Type: Drugs (Largest) vs. Non-Surgical Procedures (Fastest-Growing)

In the US hemorrhoids treatment market, the treatment type segment primarily divides into drugs, non-surgical procedures, and surgical procedures. Currently, drugs dominate the market, commanding a significant share due to their accessibility and cost-effectiveness for patients. Non-surgical procedures, while smaller in share, are rapidly gaining traction as patients seek less invasive options. Surgical procedures account for a smaller market share, primarily utilized for more severe cases of hemorrhoids requiring advanced treatment.

Growth trends in the treatment type segment are notably influenced by an increasing preference for minimally invasive treatments. Non-surgical procedures are seeing the fastest growth driven by advancements in technology and better patient awareness about available treatment options. The aging population and rising prevalence of hemorrhoids also contribute to the demand for effective treatment solutions, making non-surgical methods increasingly attractive.

Drugs: Dominant vs. Non-Surgical Procedures: Emerging

Drugs represent the dominant treatment type in the US hemorrhoids treatment market, primarily due to their wide availability and ease of use. These treatments often include topical applications and oral medications that can alleviate symptoms effectively. Conversely, non-surgical procedures are emerging as a popular alternative, favored for their non-invasive nature and quick recovery times. Treatments such as rubber band ligation and [sclerotherapy](https://www.marketresearchfuture.com/reports/sclerotherapy-market-67779) are catching the attention of patients looking for options with lower risks and side effects. While drugs maintain their leading position, the growth of non-surgical methods signifies a shift in patient preferences towards safer and less invasive treatments, reflecting broader trends in healthcare seeking to minimize recovery time and hospital stays.

### By Administration Route: Oral (Largest) vs. Topical (Fastest-Growing)

The US hemorrhoids treatment market reveals a distinct segmentation between oral and topical administration routes, with oral treatments holding the largest market share. This dominance can be attributed to their convenience and effectiveness, appealing to a broad range of patients. Meanwhile, topical treatments are gaining rapidly, particularly among those seeking targeted relief with minimal systemic effects. As awareness of treatment options increases, the preference for topical solutions has started to rise, contributing to a dynamic shift in market share distribution.

Growth trends in this segment are driven by factors such as the rising incidence of hemorrhoids, increased patient awareness, and advancements in product formulations. Oral treatments continue to thrive due to their long-standing presence and established trust, while topical treatments are emerging as innovative alternatives. Enhanced marketing strategies and the introduction of over-the-counter options for topical products are expected to fuel demand further, setting the stage for robust growth in this sector.

Administration Route: Oral (Dominant) vs. Topical (Emerging)

Oral treatments in the US hemorrhoids treatment market are regarded as the dominant segment, characterized by their ease of use and broader acceptance among patients. They typically offer systemic relief, making them ideal for individuals seeking convenience in their treatment regimens. On the other hand, topical treatments are classified as the emerging segment, marked by their targeted action and preference for localized symptom relief. This sector is particularly appealing to patients who experience discomfort but prefer to avoid systemic effects. As product innovations continue to emerge, both segments are expected to evolve, with oral treatments maintaining their stronghold while topical treatments increasingly capture market attention through new formulations and a focus on patient preferences.

### By Distribution Channel: Retail Pharmacies (Largest) vs. Online Pharmacies (Fastest-Growing)

In the US hemorrhoids treatment market, the distribution of market share among the various channels is notably skewed towards retail pharmacies, which command the largest share due to their widespread presence and accessibility. Hospital pharmacies also play a significant role, particularly in providing specialized products. Online pharmacies, while currently smaller in market share, are rapidly gaining traction as consumers increasingly prefer the convenience of online shopping and the discretion it offers.

Growth trends indicate a substantial rise in the online pharmacies segment, attributed to the increasing preference for e-commerce solutions in healthcare. Factors driving this growth include the growing comfort of consumers with online transactions, the broadening of product availability, and the influence of digital marketing strategies that attract customers. The [retail pharmacy](https://www.marketresearchfuture.com/reports/retail-pharmacy-market-22432) segment remains dominant but must adapt to the rising competition from online channels to maintain its market position.

Retail Pharmacies (Dominant) vs. Online Pharmacies (Emerging)

Retail pharmacies represent the dominant distribution channel in the US hemorrhoids treatment market, characterized by easy access, personalized customer service, and the ability to provide a broad range of products fitting various consumer needs. They benefit from established relationships with healthcare providers and a loyal customer base. Conversely, online pharmacies are emerging as a significant force, appealing to the growing consumer demand for convenience and anonymity. They typically offer a wider selection of products and often more competitive pricing. As internet penetration increases and consumers become more accustomed to purchasing health-related products online, online pharmacies are expected to capture a larger market share, challenging traditional retail models.

### By End User: Hospital & Clinics (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the US Hemorrhoids Treatment Market, hospitals and clinics hold the largest share among end users, driven by their established infrastructure and comprehensive treatment offerings. This segment attracts a significant patient volume due to the accessibility of advanced medical technologies and facilities, which enhances patient trust and treatment adherence. Conversely, ambulatory surgical centers are emerging as the fastest-growing segment. Their ability to provide outpatient procedures with lower costs and quicker recovery times appeals to patients seeking efficient treatment options.

End Users: Hospitals & Clinics (Dominant) vs. Ambulatory Surgical Centers (Emerging)

The hospitals and clinics segment is characterized by a robust framework that supports a wide range of hemorrhoid treatments, from conservative management to surgical interventions. This established segment not only leads in market presence but also instills confidence in patients due to the rigorous standards of care and experienced medical professionals. On the other hand, ambulatory surgical centers are rapidly gaining traction by offering minimally invasive procedures that can be executed in a single day. Their growth is propelled by patient demand for convenience and shorter wait times, alongside a shift towards outpatient care as a sustainable healthcare model.

### US Hemorrhoids Treatment Market Country Insights

The US hemorrhoid treatment market is growing due to a rising prevalence of hemorrhoids, particularly among an aging demographic, and the demand for effective treatments is increasing. The market's trajectory is shaped by advancements in medical technologies, a trend towards less invasive procedures, and the expertise of proctologist specialists. Additionally, hospitals and clinics play a crucial role in providing comprehensive care, offering a range of treatment options, and contributing significantly to the market's expansion. Increased awareness, education, and the availability of over-the-counter products further bolster the growth of the hemorrhoids treatment market, creating a dynamic landscape in the United States.

## Regional Market Share Analysis

### North America : Market Leader in Treatment

The North American market for hemorrhoids treatment is primarily driven by an aging population, increasing prevalence of obesity, and rising awareness about treatment options. The U.S. holds the largest market share at approximately 70%, followed by Canada at around 15%. Regulatory support from agencies like the FDA has also catalyzed market growth, ensuring the availability of innovative treatment solutions. In this region, the competitive landscape is characterized by the presence of major players such as Johnson & Johnson, Medtronic, and Boston Scientific. These companies are focusing on product innovation and strategic partnerships to enhance their market position. The U.S. market is also witnessing a surge in minimally invasive procedures, which are gaining popularity due to their effectiveness and reduced recovery times.

### Europe : Emerging Market Dynamics

Europe is witnessing a growing demand for hemorrhoids treatment driven by increasing healthcare expenditure and a rising geriatric population. The market is expected to expand significantly, with Germany and the UK being the largest contributors, holding approximately 30% and 25% of the market share, respectively. Regulatory frameworks in the EU are evolving to support innovative treatment methods, enhancing patient access to care. Leading countries in Europe are focusing on advanced treatment technologies, with key players like Bayer AG and Coloplast A/S leading the charge. The competitive landscape is marked by a mix of established companies and emerging startups, all vying for market share through innovative solutions. The emphasis on patient-centric care is also shaping the market, leading to the development of tailored treatment options.

### Asia-Pacific : Rapid Growth Potential

The Asia-Pacific region is rapidly emerging as a significant market for hemorrhoids treatment, driven by increasing urbanization, changing lifestyles, and a growing awareness of health issues. Countries like China and India are leading the market, collectively accounting for about 40% of the regional share. The rise in disposable incomes and healthcare investments is further propelling market growth, alongside supportive government initiatives aimed at improving healthcare access. In this region, the competitive landscape is evolving, with both local and international players entering the market. Companies such as Stryker Corporation and Hollister Incorporated are expanding their presence, focusing on innovative treatment solutions. The demand for minimally invasive procedures is also on the rise, reflecting a shift in patient preferences towards less invasive options that offer quicker recovery times.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region presents untapped opportunities in the hemorrhoids treatment market, driven by increasing healthcare investments and a growing awareness of gastrointestinal health. Countries like South Africa and the UAE are leading the market, holding approximately 25% and 20% of the regional share, respectively. The region is witnessing a gradual shift towards modern healthcare practices, supported by government initiatives aimed at enhancing healthcare infrastructure. The competitive landscape is characterized by a mix of local and international players, with companies like 3M Company and Smith & Nephew making significant inroads. The focus is on expanding access to advanced treatment options, with an emphasis on education and awareness campaigns to inform the population about available treatments. As healthcare systems evolve, the demand for effective hemorrhoids treatments is expected to rise significantly.

## Competitive Benchmarking

The hemorrhoids treatment market exhibits a competitive landscape characterized by a blend of established players and emerging innovators. Key growth drivers include an increasing prevalence of hemorrhoids, heightened awareness of treatment options, and advancements in minimally invasive procedures. Major companies such as Johnson & Johnson (US), Bayer AG (DE), and Procter & Gamble Co (US) are strategically positioned to leverage their extensive product portfolios and research capabilities. Johnson & Johnson (US) focuses on innovation in over-the-counter treatments, while Bayer AG (DE) emphasizes partnerships to enhance its product offerings. Procter & Gamble Co (US) is investing in digital marketing strategies to reach a broader audience, collectively shaping a competitive environment that prioritizes consumer engagement and product accessibility.
The market structure appears moderately fragmented, with a mix of large multinational corporations and smaller specialized firms. Key players are adopting various business tactics, such as localizing manufacturing to reduce costs and optimize supply chains. This approach not only enhances operational efficiency but also allows companies to respond swiftly to market demands. The collective influence of these players fosters a dynamic competitive atmosphere, where agility and responsiveness are paramount.
In October 2025, Johnson & Johnson (US) announced the launch of a new line of topical treatments aimed at providing faster relief for hemorrhoid symptoms. This strategic move is significant as it aligns with the growing consumer demand for effective and convenient treatment options. By expanding its product range, Johnson & Johnson (US) reinforces its market leadership and addresses the needs of a diverse patient demographic.
In September 2025, Bayer AG (DE) entered into a strategic partnership with a digital health startup to develop a mobile application that offers personalized treatment plans for hemorrhoid sufferers. This initiative reflects Bayer's commitment to integrating technology into healthcare solutions, potentially enhancing patient adherence and satisfaction. Such collaborations may position Bayer AG (DE) as a frontrunner in the digital health space within the hemorrhoids treatment market.
In August 2025, Procter & Gamble Co (US) launched a targeted marketing campaign focusing on the importance of early intervention in hemorrhoid treatment. This campaign not only aims to educate consumers but also seeks to destigmatize the condition, encouraging individuals to seek help sooner. By addressing societal perceptions, Procter & Gamble Co (US) is likely to expand its customer base and drive sales growth in a traditionally sensitive market.
As of November 2025, current competitive trends indicate a shift towards digitalization, sustainability, and the integration of artificial intelligence in treatment solutions. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve from price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the necessity for companies to adapt and innovate continuously in order to maintain a competitive edge.

## Recent News & Developments

**In June 2022,** ProNova Partners (US), a mergers and acquisitions firm based in the United States, was permitted to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive device to eliminate hemorrhoids.

**In June 2022,**Medtronic (Ireland) announced the launch of its new hemorrhoid treatment device, the HET Bipolar System, which treats internal hemorrhoids in a gentle, non-surgical manner. The system delivers bipolar energy to the hemorrhoid tissue, which causes coagulation and subsequent necrosis.

## Report Scope

| MARKET SIZE 2024 | 302.73(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 323.53(USD Million) |
| MARKET SIZE 2035 | 628.87(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.87% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Johnson & Johnson (US), Bayer AG (DE), Procter & Gamble Co (US), Medtronic plc (IE), Hollister Incorporated (US), SurgiCare (US), B. Braun Melsungen AG (DE), Smith & Nephew plc (GB), Coloplast A/S (DK) |
| Segments Covered | Treatment Type, Administration Route, Distribution Channel |
| Key Market Opportunities | Emergence of minimally invasive procedures enhances patient preference in the hemorrhoids treatment market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in hemorrhoids treatment options and competitive market dynamics. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US hemorrhoids treatment market in 2024?**
A: The market valuation was 302.73 USD Million in 2024.

**Q: What is the projected market valuation for the US hemorrhoids treatment market by 2035?**
A: The projected valuation for 2035 is 628.87 USD Million.

**Q: What is the expected CAGR for the US hemorrhoids treatment market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.87% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the US hemorrhoids treatment market?**
A: Key players include Johnson & Johnson, Bayer AG, Procter & Gamble Co, Medtronic plc, and Hollister Incorporated.

**Q: What were the revenue figures for drugs in the US hemorrhoids treatment market in 2024?**
A: The revenue for drugs was 80.82 USD Million in 2024, projected to reach 170.0 USD Million.

**Q: How do non-surgical procedures compare to surgical procedures in terms of market valuation?**
A: Non-surgical procedures had a valuation of 121.09 USD Million in 2024, increasing to 250.0 USD Million, while surgical procedures ranged from 100.82 USD Million to 208.87 USD Million.

**Q: What are the two main administration routes for hemorrhoids treatment?**
A: The two main administration routes are oral, with revenues from 121.09 USD Million to 257.77 USD Million, and topical, ranging from 181.64 USD Million to 371.1 USD Million.

**Q: Which distribution channel had the highest revenue in the US hemorrhoids treatment market in 2024?**
A: Retail pharmacies generated the highest revenue at 121.09 USD Million, projected to reach 257.12 USD Million.

**Q: What is the expected growth trend for online pharmacies in the US hemorrhoids treatment market?**
A: Online pharmacies had revenues of 121.1 USD Million in 2024, expected to grow to 243.19 USD Million by 2035.

**Q: How does the market for topical treatments compare to oral treatments in terms of projected growth?**
A: Topical treatments are projected to grow from 181.64 USD Million to 371.1 USD Million, while oral treatments are expected to increase from 121.09 USD Million to 257.77 USD Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-hemorrhoids-treatment-market-16261*